Longfellow Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Longfellow Investment Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-81,832	Closed	-$1.13M	–	262
2026 Q1	$1.13M	Hold	81,832	–	–	0.24%	72
2025 Q4	$1.15M	Sell	81,832 -12,527	-13%	-$176K	0.26%	68
2025 Q3	$1.32M	Buy	94,359 +22,847	+32%	+$329K	0.31%	51
2025 Q2	$1.07M	Buy	71,512 +15,417	+27%	+$220K	0.27%	68
2025 Q1	$740K	Hold	56,095	–	–	0.18%	79
2024 Q4	$886K	Hold	56,095	–	–	0.23%	62
2024 Q3	$891K	Hold	56,095	–	–	0.22%	64
2024 Q2	$855K	Hold	56,095	–	–	0.21%	63
2024 Q1	$823K	Hold	56,095	–	–	0.19%	62
2023 Q4	$781K	Hold	56,095	–	–	0.19%	64
2023 Q3	$750K	Hold	56,095	–	–	0.2%	66
2023 Q2	$708K	Buy	+56,095	New	+$655K	0.16%	85

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Longfellow Investment Management's RDY Position: Q2 2026 in Review

Longfellow Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 81,832 shares — an estimated $1.13M sold.

Longfellow Investment Management first reported a position in RDY in Q2 2023 and held it in 12 quarters. The position peaked at $1.32M in Q3 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Longfellow Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
Longfellow Investment Management sold 81,832 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $1.13M.
Longfellow Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2023 and held it in 12 quarters.
Longfellow Investment Management's Dr. Reddy's Laboratories position peaked at $1.32M in Q3 2025.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Longfellow Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.